Parkinson disease and other neurodegenerative movement disorders: clinical and experimental research

News

Clínic Barcelona

Research January 13 2023

Research provides new clues about iron toxicity in Parkinson's disease and explains the paradoxical effect of deferiprone

The results contrast with those of 4 previous independent clinical trials and could provide relevant information on the role of iron accumulation in1

Clínic Barcelona

Research July 20 2022

The combination of biomarkers in cerebrospinal fluid and magnetic resonance imaging enables differentiation between Parkinson’s disease and atypical parkinsonisms

The results of the study, led by Clínic-IDIBAPS researchers, could contribute to improving diagnosis of the disease.

Clínic Barcelona

Research June 21 2022

The Hospital CLÍNIC-IDIBAPS is leading a study to identify people who may develop Parkinson’s disease

Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease,1

Clínic Barcelona

INTERVIEW April 11 2022

Dr. Mª Josep Martí: "The main aim is to slow down, stop or even reverse the processes of the disease”

Interview with Dr. Mª Josep Martí, neurologist and head of the IDIBAPS Parkinson’s Disease and other Neurodegenerative Movement Disorders research gr1

Clínic Barcelona

Research March 8 2022

Possible biomarker for progression of genetic Parkinson disease identified

Researchers at Hospital Clínic-IDIBAPS have observed changes in the phosphorylation pattern of certain proteins associated with a mutation in the gen1

3 3

page1
page2
page3 , current page.

News

Research provides new clues about iron toxicity in Parkinson's disease and explains the paradoxical effect of deferiprone

The combination of biomarkers in cerebrospinal fluid and magnetic resonance imaging enables differentiation between Parkinson’s disease and atypical parkinsonisms

The Hospital CLÍNIC-IDIBAPS is leading a study to identify people who may develop Parkinson’s disease

Dr. Mª Josep Martí: "The main aim is to slow down, stop or even reverse the processes of the disease”

Possible biomarker for progression of genetic Parkinson disease identified

navigation between pages below